Published in Vopr Virusol on November 21, 1979
Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus. Influenza Other Respir Viruses (2010) 0.81
Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine (1986) 1.01
Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains. J Gen Virol (1981) 0.98
[Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus]. Vopr Virusol (1977) 0.94
Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infect Immun (1984) 0.94
Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infect Immun (1984) 0.93
Testing the safety and effectiveness of oral administration of a live influenza vaccine. Bull World Health Organ (1970) 0.91
[Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination]. Vopr Onkol (1996) 0.89
Conditions for production of thermosensitive attenuated influenza virus recombinants. Acta Virol (1978) 0.87
Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle. Acta Virol (1980) 0.86
Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus. Acta Virol (1982) 0.86
Pathogenicity of cryophilic and thermophilic strains of influenza type A2 virus for developing chick embryos and albino mice. Acta Virol (1969) 0.84
[Experience in selecting safe heat-sensitive influenza virus A recombinants]. Vopr Virusol (1979) 0.84
[The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants]. Vopr Virusol (1995) 0.82
Temperature-sensitive recombinants of influenzavirus B. Acta Virol (1978) 0.79
[The effect of amplifying reproduction of influenza virus in mouse lungs during simultaneous infection with two cold-adapted strains]. Vopr Virusol (1990) 0.78
[The reactive and immunogenic properties and epidemiological effectiveness of further attenuated influenza virus vaccinal strains (observed in preschool children)]. Vopr Virusol (1966) 0.78
[Results in the study of a special live influenza vaccine variant for the immunization of preschool and young school-age children]. Vestn Akad Med Nauk SSSR (1968) 0.77
[Epidemiologic effectiveness of live enteral adenovirus and influenza vaccine on susceptible groups of adults]. Vestn Akad Med Nauk SSSR (1968) 0.77
[Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57]. Vopr Virusol (1986) 0.76
Interfering activity of virulent and attenuated influenza virus strains. Acta Virol (1976) 0.76
[The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14]. Vopr Virusol (1992) 0.76
Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study. J Hyg Epidemiol Microbiol Immunol (1979) 0.75
[Correlations between thermosensitivity and interference activity of the influenza virus]. Virologie (1981) 0.75
[Differentiating markers of virulent and attenuated (cold-adapted) strains of influenza A virus]. Vopr Virusol (1977) 0.75
[Variations in the temperature range for reproduction of virulent and attenuated cold-adapted influenza A viruses]. Vopr Virusol (1989) 0.75
[Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)]. Vopr Virusol (2007) 0.75
[Comprehensive prophylactic examinations of women for the detection of early forms of breast cancer]. Vopr Onkol (1978) 0.75
Study of the avidity of anti-influenza antibodies in sera of convalescents or subjects vaccinated with a live influenza virus vaccine. Acta Virol (1969) 0.75
[Live influenza vaccine in the USSR: its development, study and practical use]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[ts-Mutations in the genomes of cold-adapted variants of influenza A/Hong Kong/1/68(H3N2) and A/Victoria/35/72(H3N2) viruses]. Genetika (1993) 0.75
[The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. Vopr Virusol (1990) 0.75
[Attenuated recombinant influenza type B virus obtained during crossing of virus B/Ann Arbor/2/86 with the cold-adapted strain B/Leningrad/14/17/55]. Vopr Virusol (1990) 0.75
[Present status of the problem of vaccinoprophylaxis against influenza and acute respiratory diseases]. Vestn Akad Med Nauk SSSR (1975) 0.75
[Comparative characteristics of reactogenic and immunogenic properties of the attenuated live influenza vaccine in intranasal and peroral administration in children]. Pediatriia (1969) 0.75
Peculiarities of obtaining and characterization of a cold-adapted A/PR/8/34 influenza virus variant. Acta Virol (1984) 0.75
[Results of controlled observation of the selection of vaccine strains of influenza virus]. Vopr Virusol (1969) 0.75
[Results and prospects for vaccinal prevention of influenza]. Vopr Virusol (1977) 0.75
[Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children]. Vopr Virusol (1984) 0.75
Partial change of the ts-phenotype of cold-adapted influenza virus strain grown in canine kidney cells in the presence of trypsin. Acta Virol (1982) 0.75
[The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]. Vopr Virusol (1994) 0.75
Analysis of antigenic and biological properties of influenza B virus strains, isolated in Leningrad in 1955-1967. Acta Virol (1971) 0.75
[Basis of the anthroponotic nature of human pandemic influenza A viruses]. Vopr Virusol (1981) 0.75
[Ways of further reduction of the incidence of tuberculosis among adolescents]. Probl Tuberk (1977) 0.75
[The evaluation of the degree of attenuation of cold-adapted influenza A virus strains in CBA-strain mouse and Syrian hamster models]. Vopr Virusol (1992) 0.75
[Use of adriamycin in the treatment of metastatic breast cancer]. Vopr Onkol (1984) 0.75
[Evaluation of the preventive activity of the new anti-influenza drug, amantadine]. Vrach Delo (1969) 0.75
[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains]. Vopr Virusol (2005) 0.75
[The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics]. Vopr Virusol (1991) 0.75
[Interference and its overcoming during the reproduction of 2 influenza A virus strains in an experiment]. Vopr Virusol (1993) 0.75
[Lymphangiosarcoma of the upper extremity after mastectomy for cancer]. Vestn Khir Im I I Grek (1981) 0.75
[Genetic basis for construction of the life influenza type A vaccine using temperature-sensitive mutants]. Mol Gen Mikrobiol Virusol (1990) 0.75
[Use of "split" courses of combination chemotherapy in breast cancer]. Vopr Onkol (1981) 0.75
[Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome]. Vopr Virusol (1995) 0.75
[Analysis of the polypeptides of epidemic strains and heat-sensitive variants of the influenza virus]. Tr Inst Im Pastera (1982) 0.75
[Antitumor activity of cold-adapted strains of influenza virus in a model transformed murine tumor cells]. Vopr Virusol (1999) 0.75
Interfering activity of epidemic, attenuated and recombinant strains of influenza A virus. Acta Virol (1986) 0.75
[The possibility of the circulation of vaccinal influenza A viral strains in the biosphere]. Dokl Akad Nauk SSSR (1990) 0.75
[Role of temperature-sensitive mutants in the natural evolution of the influenza virus]. Vopr Virusol (1986) 0.75
[The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains]. Vopr Virusol (2003) 0.75
[Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants]. Vopr Virusol (1984) 0.75
[Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)]. Vopr Virusol (1991) 0.75
[Criteria of primary screening of attenuated strains for live vaccine against Influenza A]. Vopr Virusol (2001) 0.75
Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains. Acta Virol (1984) 0.75
Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination. Acta Virol (1980) 0.75
Correlation between reproductive and interfering activities of epidemic and thermosensitive influenza virus strains. Acta Virol (1982) 0.75